Article
A cell surface tethered enzyme improves efficiency in gene-directed enzyme prodrug therapy.
Nature biotechnology - 1 Dec 1997
Marais R, Spooner R A, Stribbling S M, Light Y, Martin J, Springer C J
Abstract excerpt
The potential for expressing the bacterial enzyme carboxypeptidase G2 (CPG2) tethered to the outer surface of mammalian cells was examined for use in gene-directed enzyme prodrug therapy. The affinity of CPG2 for the substrate methotrexate was unaffected by three mutations required to prevent N-linked glycosylation. Breast carcinoma MDA MB 361 cells expressing CPG2 internally showed only a very modest increase in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
